Benson S Chellakkan

5PUBLICATIONS
73CO-AUTHORS
Cancer diagnosisMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 06, 2026
The Lysine Demethylase KDM4C Is an Oncogenic Driver and Regulates ERK Activity in KRAS-Mutant Pancreatic Ductal Adenocarcinoma.

Menna-T-Allah Shaheen, Sarah Dhebat, Kimal I Rajapakshe

|Sep 03, 2025
An allele-agnostic mutant-KRAS inhibitor suppresses tumor maintenance signals and reprograms tumor immunity in pancreatic cancer.

Kathleen M McAndrews, Francesca Paradiso, Clint A Stalnecker

|Mar 23, 2022
Listeria delivers tetanus toxoid protein to pancreatic tumors and induces cancer cell death in mice.

Benson Chellakkan Selvanesan, Dinesh Chandra, Wilber Quispe-Tintaya

|Nov 06, 2020
Nicotinamide combined with gemcitabine is an immunomodulatory therapy that restrains pancreatic cancer in mice.

Benson Chellakkan Selvanesan, Kiran Meena, Amanda Beck

Pageof 1